510(k) Report

510(k) · Cleared

Recalled · Class I · 2026

Namic Angiographic Syringe

K873955510(k) TraditionalCleared Feb 5, 1988130-day reviewClass II21 CFR 870.1650Recalls 1 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

North American Instrument Corp. · DXT Injector And Syringe, Angiographic

Cleared on Feb 5, 1988 after a 130-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 2 of the 9 devices in its family, counting itself, have a Class I recall. 8 later devices descend from it. It has been recalled once, including a Class I recall.

Decided
Feb 5, 1988
Review
130 days
Class
Class II
Product code
DXT
Recalls
1 (1 Class I)
Predicates
0

8 later devices descend from it, 2 citing it directly. 2 of the 9 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2011: 1 descendant cleared, 1 with a Class I recall12014: 1 descendant cleared2017: 1 descendant cleared2019: 1 descendant cleared2024: 1 descendant cleared2021: 1 descendant cleared2022: 1 descendant cleared2025: 1 descendant cleared1990200020102020
  1. This deviceK873955 Namic Angiographic SyringeNorth American Instrument Corp. · 1988
  2. Descendant · cites it directly · 7 of its ownK113198 Nmi Control Syringe, 7 ML Nmi Control Syringe, 8 MLNavilyst Medical, Inc. · 2011 · Recalled (Class I)
  3. Descendant · cites it directly · 4 of its ownK140194 Namic RCS SyringeNavilyst Medical, Inc. · 2014
  4. Descendant · 2 generations on · 3 of its ownK191659 Instylla Delivery KitInstylla, Inc. · 2019
  5. Descendant · 3 generations on · 2 of its ownK202544 Instylla Delivery KitInstylla, Inc. · 2021
  6. Descendant · 3 generations on · 1 of its ownK213632 Instylla Delivery KitInstylla, Inc. · 2022

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2011: 12014: 12017: 12019: 12021: 12022: 12024: 12025: 1
2011high 1 (2011) · low 0 (2012)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 8 · See all
  • K113198Nmi Control Syringe, 7 ML Nmi Control Syringe, 8 MLNavilyst Medical, Inc. · 2011 · cites it directly7descendants
  • K140194Namic RCS SyringeNavilyst Medical, Inc. · 2014 · cites it directly4descendants
  • K191659Instylla Delivery KitInstylla, Inc. · 2019 · 2 generations on3descendants
  • K202544Instylla Delivery KitInstylla, Inc. · 2021 · 3 generations on2descendants
  • K213632Instylla Delivery KitInstylla, Inc. · 2022 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K873955Namic Angiographic SyringeNorth American Instrument Corp.1988—
+1K113198Nmi Control Syringe, 7 ML Nmi Control Syringe, 8 MLNavilyst Medical, Inc.2011Class I
+1K140194Namic RCS SyringeNavilyst Medical, Inc.2014—
+2K191659Instylla Delivery KitInstylla, Inc.2019—
+3K202544Instylla Delivery KitInstylla, Inc.2021—
+3K213632Instylla Delivery KitInstylla, Inc.2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201111
201410
201710
201910
202110
202210
202410
202510
FIG. 1 — Lineage of K873955, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DXT device

  1. #1 K253048 High Pressure Syringe; Pressure Connecting…score 13.6 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (8)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113198Nmi Control Syringe, 7 ML Nmi Control Syringe, 8 ML Class INavilyst Medical, Inc.20117
K140194Namic RCS SyringeNavilyst Medical, Inc.20144

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Feb 27, 2026Class IZ-1712-2026Under Investigation by firmMedline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K113198Nmi Control Syringe, 7 ML Nmi Control Syringe, 8 MLNavilyst Medical, Inc. · 2011 · Cites it directly · ◆ in the 2011 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K113198 (Navilyst Medical, Inc., 2011) has gone furthest, with 7 descendants of its own.

How does its category compare?

All DXT devices

DXT Injector And Syringe, Angiographic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DXT

1in 2025

2007: 32008: 22009: 62010: 12011: 42013: 22014: 62015: 72016: 82017: 72018: 92019: 42020: 32021: 12023: 12024: 42025: 12026 (partial year): 7
2007high 9 (2018) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXT

138in 2024

2007: 182 days median2009: 137 days median2011: 69 days median2014: 144 days median2015: 153 days median2016: 172 days median2017: 183 days median2018: 93 days median2019: 96 days median2020: 154 days median2024: 138 days median2026 (partial year): 264 days median
2007high 264 (2026) · low 69 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DXT

10in 2024

2007: 42008: 32009: 72010: 32011: 32012: 72015: 12018: 22020: 12021: 12023: 22024: 102026 (partial year): 6
2007high 10 (2024) · low 0 (2013)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DXT

97in 2025

2007: 1072008: 1682009: 1882010: 1242011: 1332012: 1352013: 1412014: 972015: 1352016: 1522017: 1282018: 1292019: 1212020: 932021: 1322022: 1112023: 1172024: 1182025: 97
2007high 188 (2009) · low 93 (2020)2025

MAUDE reports naming product code DXT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200731824107
20082—3168
200961377188
20101—3124
20114693133
20120—7135
20132—0141
20146144097
201571531135
201681720152
201771830128
20189932129
20194960121
20203154193
20211—1132
20220—0111
20231—2117
2024413810118
20251—097
202672646—
Cite this page

510(k) Report. “K873955: Namic Angiographic Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K873955

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026